Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Schmidt

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|April 11, 1991
A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study GroupG M Schmidt, D A Horak, J C Niland, et al.
Blut|February 19, 1979
The use of lymphocyte phosphoglucomutase as a genetic marker in bone marrow transplant recipientsG M Schmidt, K G Blume, K J Bross, et al.
Protein Expression and Purification|September 10, 2013
Development of the Twin-Strep-tag® and its application for purification of recombinant proteins from cell culture supernatantsThomas G M Schmidt, Lilia Batz, Lidia Bonet, et al.
Journal of Clinical Microbiology|December 1, 1990
Comparative analysis of human cytomegalovirus a-sequence in multiple clinical isolates by using polymerase chain reaction and restriction fragment length polymorphism assaysJ A Zaia, G Gallez-Hawkins, M A Churchill, et al.
Blut|July 1, 1987
Allogeneic bone marrow transplantation for high risk non-Hodgkin's lymphoma during first complete remissionA P Nademanee, S J Forman, G M Schmidt, et al.
Journal of Clinical Microbiology|September 1, 1994
Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipientsM M Aspin, G M Gallez-Hawkins, T D Giugni, et al.
The New England Journal of Medicine|August 7, 1986
A second isolate of HTLV-II associated with atypical hairy-cell leukemiaJ D Rosenblatt, D W Golde, W Wachsman, et al.
Blood|August 1, 1995
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisoneA Nademanee, G M Schmidt, P Parker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patientsM R O'Donnell, G M Schmidt, B R Tegtmeier, et al.
Blood|September 1, 1992
High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot studyA Nademanee, G M Schmidt, M R O'Donnell, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|April 11, 1991
A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study GroupG M Schmidt, D A Horak, J C Niland, et al.
Blut|February 19, 1979
The use of lymphocyte phosphoglucomutase as a genetic marker in bone marrow transplant recipientsG M Schmidt, K G Blume, K J Bross, et al.
Protein Expression and Purification|September 10, 2013
Development of the Twin-Strep-tag® and its application for purification of recombinant proteins from cell culture supernatantsThomas G M Schmidt, Lilia Batz, Lidia Bonet, et al.
Journal of Clinical Microbiology|December 1, 1990
Comparative analysis of human cytomegalovirus a-sequence in multiple clinical isolates by using polymerase chain reaction and restriction fragment length polymorphism assaysJ A Zaia, G Gallez-Hawkins, M A Churchill, et al.
Blut|July 1, 1987
Allogeneic bone marrow transplantation for high risk non-Hodgkin's lymphoma during first complete remissionA P Nademanee, S J Forman, G M Schmidt, et al.
Journal of Clinical Microbiology|September 1, 1994
Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipientsM M Aspin, G M Gallez-Hawkins, T D Giugni, et al.
The New England Journal of Medicine|August 7, 1986
A second isolate of HTLV-II associated with atypical hairy-cell leukemiaJ D Rosenblatt, D W Golde, W Wachsman, et al.
Blood|August 1, 1995
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisoneA Nademanee, G M Schmidt, P Parker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patientsM R O'Donnell, G M Schmidt, B R Tegtmeier, et al.
Blood|September 1, 1992
High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot studyA Nademanee, G M Schmidt, M R O'Donnell, et al.
Pageof 9